These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 26752676)

  • 1. Identification of Individual Cancer-Specific Somatic Mutations for Neoantigen-Based Immunotherapy of Lung Cancer.
    Karasaki T; Nagayama K; Kawashima M; Hiyama N; Murayama T; Kuwano H; Nitadori J; Anraku M; Sato M; Miyai M; Hosoi A; Matsushita H; Kikugawa S; Matoba R; Ohara O; Kakimi K; Nakajima J
    J Thorac Oncol; 2016 Mar; 11(3):324-33. PubMed ID: 26752676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction and prioritization of neoantigens: integration of RNA sequencing data with whole-exome sequencing.
    Karasaki T; Nagayama K; Kuwano H; Nitadori JI; Sato M; Anraku M; Hosoi A; Matsushita H; Takazawa M; Ohara O; Nakajima J; Kakimi K
    Cancer Sci; 2017 Feb; 108(2):170-177. PubMed ID: 27960040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors.
    Chen F; Zou Z; Du J; Su S; Shao J; Meng F; Yang J; Xu Q; Ding N; Yang Y; Liu Q; Wang Q; Sun Z; Zhou S; Du S; Wei J; Liu B
    J Clin Invest; 2019 May; 129(5):2056-2070. PubMed ID: 30835255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic analysis of 63,220 tumors reveals insights into tumor uniqueness and targeted cancer immunotherapy strategies.
    Hartmaier RJ; Charo J; Fabrizio D; Goldberg ME; Albacker LA; Pao W; Chmielecki J
    Genome Med; 2017 Feb; 9(1):16. PubMed ID: 28231819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalized neoantigen vaccines: A new approach to cancer immunotherapy.
    Aldous AR; Dong JZ
    Bioorg Med Chem; 2018 Jun; 26(10):2842-2849. PubMed ID: 29111369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neoantigens and Whole-Exome Sequencing].
    Karasaki T; Nakajima J; Kakimi K
    Gan To Kagaku Ryoho; 2016 Jul; 43(7):791-7. PubMed ID: 27431622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized neoantigen pulsed dendritic cell vaccine for advanced lung cancer.
    Ding Z; Li Q; Zhang R; Xie L; Shu Y; Gao S; Wang P; Su X; Qin Y; Wang Y; Fang J; Zhu Z; Xia X; Wei G; Wang H; Qian H; Guo X; Gao Z; Wang Y; Wei Y; Xu Q; Xu H; Yang L
    Signal Transduct Target Ther; 2021 Jan; 6(1):26. PubMed ID: 33473101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shared neoantigens: ideal targets for off-the-shelf cancer immunotherapy.
    Zhao W; Wu J; Chen S; Zhou Z
    Pharmacogenomics; 2020 Jun; 21(9):637-645. PubMed ID: 32423288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pTuneos: prioritizing tumor neoantigens from next-generation sequencing data.
    Zhou C; Wei Z; Zhang Z; Zhang B; Zhu C; Chen K; Chuai G; Qu S; Xie L; Gao Y; Liu Q
    Genome Med; 2019 Oct; 11(1):67. PubMed ID: 31666118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Immunogram for the Cancer-Immunity Cycle: Towards Personalized Immunotherapy of Lung Cancer.
    Karasaki T; Nagayama K; Kuwano H; Nitadori JI; Sato M; Anraku M; Hosoi A; Matsushita H; Morishita Y; Kashiwabara K; Takazawa M; Ohara O; Kakimi K; Nakajima J
    J Thorac Oncol; 2017 May; 12(5):791-803. PubMed ID: 28088513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoantigen vaccine: an emerging tumor immunotherapy.
    Peng M; Mo Y; Wang Y; Wu P; Zhang Y; Xiong F; Guo C; Wu X; Li Y; Li X; Li G; Xiong W; Zeng Z
    Mol Cancer; 2019 Aug; 18(1):128. PubMed ID: 31443694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine.
    Garofalo A; Sholl L; Reardon B; Taylor-Weiner A; Amin-Mansour A; Miao D; Liu D; Oliver N; MacConaill L; Ducar M; Rojas-Rudilla V; Giannakis M; Ghazani A; Gray S; Janne P; Garber J; Joffe S; Lindeman N; Wagle N; Garraway LA; Van Allen EM
    Genome Med; 2016 Jul; 8(1):79. PubMed ID: 27460824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-exome sequencing to identify novel somatic mutations in squamous cell lung cancers.
    Zheng CX; Gu ZH; Han B; Zhang RX; Pan CM; Xiang Y; Rong XJ; Chen X; Li QY; Wan HY
    Int J Oncol; 2013 Sep; 43(3):755-64. PubMed ID: 23799614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoantigen landscape supports feasibility of personalized cancer vaccine for follicular lymphoma.
    Ramirez CA; Becker-Hapak M; Singhal K; Russler-Germain DA; Frenkel F; Barnell EK; McClain ED; Desai S; Schappe T; Onyeador OC; Kudryashova O; Belousov V; Bagaev A; Ocheredko E; Kiwala S; Hundal J; Skidmore ZL; Watkins MP; Mooney TB; Walker JR; Krysiak K; Gomez F; Fronick CC; Fulton RS; Schreiber RD; Mehta-Shah N; Cashen AF; Kahl BS; Ataullakhanov R; Bartlett NL; Griffith M; Griffith OL; Fehniger TA
    Blood Adv; 2024 Aug; 8(15):4035-4049. PubMed ID: 38713894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of personal and shared frameshift neoantigen vaccines in a mouse mammary cancer model.
    Peterson M; Murphy SN; Lainson J; Zhang J; Shen L; Diehnelt CW; Johnston SA
    BMC Immunol; 2020 May; 21(1):25. PubMed ID: 32370785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low Mutation Burden in Ovarian Cancer May Limit the Utility of Neoantigen-Targeted Vaccines.
    Martin SD; Brown SD; Wick DA; Nielsen JS; Kroeger DR; Twumasi-Boateng K; Holt RA; Nelson BH
    PLoS One; 2016; 11(5):e0155189. PubMed ID: 27192170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in personalized neoantigen vaccines for cancer immunotherapy.
    Sun C; Xu S
    Biosci Trends; 2020 Nov; 14(5):349-353. PubMed ID: 32908077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of immunogenic HLA class I and II neoantigens using surrogate immunopeptidomes.
    Tokita S; Fusagawa M; Matsumoto S; Mariya T; Umemoto M; Hirohashi Y; Hata F; Saito T; Kanaseki T; Torigoe T
    Sci Adv; 2024 Sep; 10(38):eado6491. PubMed ID: 39292790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personalized vaccines for cancer immunotherapy.
    Sahin U; Türeci Ö
    Science; 2018 Mar; 359(6382):1355-1360. PubMed ID: 29567706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy for Lung Malignancies: From Gene Sequencing to Novel Therapies.
    Chee J; Robinson BW; Holt RA; Creaney J
    Chest; 2017 Apr; 151(4):891-897. PubMed ID: 27769776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.